Mohan Srinivasan

USPTO Granted Patents = 78 (Patent Applications = 30)

CIPO Patents = 10 (Patent Applications = 14)

EPO Patents = 27 (Patent Applications = 35)

Average Co-Inventor Count = 5.8

ph-index = 21

Forward Citations = 3,488(Granted Patents)

Forward Citations (Not Self Cited) = 3,315(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Santa Clara, CA (US) (2009 - 2011)
San Jose, CA (US) (2010 - 2019)
Cupertino, CA (US) (2006 - 2024)

Company Filing History:

33 out of 3,684

Bristol-myers Squibb Compnay

E. R. Squibb Sons, Inc.

patents

4. 8 out of 575

Ono Pharmaceutical Co., Ltd.

patents

5. 7 out of 540

Network Appliance, Inc.

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

CD25 Polypeptides

Anti-CD27 Antibodies

TIGIT Antibodies

GITR Antibodies

OX-40 Antibodies

LAG-3 Optimization

Monoclonal Antibodies

PD-1 Antibodies

PD-L1 Antibodies

Bispecific Antibodies

Cancer Diagnostics

Inflammation Treatment

78 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441803 - Engineered CD25 polypeptides and uses thereof (2025-10-14),

2. 12215163 - CD25 antibodies (2025-02-04),

3. 12110337 - Anti-CD27 antibodies and uses thereof (2024-10-08),

4. 12060421 - Antibodies to TIGIT (2024-08-13),

5. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

6. 11708405 - IP-10 antibodies and their uses (2023-07-25),

7. 11623965 - Prodruggable antibodies, prodrugs thereof, and methods of use and making (2023-04-11),

8. 11466092 - Antibodies against OX-40 and uses thereof (2022-10-11),

9. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

10. 11352440 - Antibodies against CD73 and uses thereof (2022-06-07),

11. 11345752 - Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2022-05-31),

12. 11242393 - Antibodies against MICA and/or MICB and uses thereof (2022-02-08),

13. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

14. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

15. 11072664 - Interferon receptor 1 antibodies and their uses (2021-07-27),

Title: Mohan Srinivasan: Pioneering Inventor from Cupertino

Introduction: Mohan Srinivasan is a distinguished inventor based in Cupertino, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mohan Srinivasan holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Mohan Srinivasan has worked with top tech companies, leading research institutions, and universities, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Mohan Srinivasan has collaborated with renowned inventors, patent attorneys, and research teams worldwide, fostering a culture of innovation and knowledge sharing that has led to significant advancements in various technological domains.

Conclusion: Mohan Srinivasan's passion for innovation, coupled with his relentless drive to solve complex problems, has solidified his reputation as a visionary inventor at the forefront of technological progress.

This text is generated by artificial intelligence and may not be accurate.